{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is BIOLASE, Inc. technically bullish or bearish?
As of January 2, 2025, BIOLASE, Inc. is in a neutral technical trend with mixed signals, showing a shift from mildly bearish to sideways, as indicated by weak indicators and no clear momentum.
Who are in the management team of BIOLASE, Inc.?
As of March 2022, the management team of BIOLASE, Inc. includes Dr. Jonathan Lord (Independent Chairman), Mr. Todd Norbe (President and CEO), and several Independent Directors: Dr. Michael DiTolla, Dr. Richard Lanman, Mr. Jess Roper, Mr. Garrett Sato, and Dr. Elaine Wagner.
What does BIOLASE, Inc. do?
BIOLASE, Inc. is a medical device company specializing in laser systems for dentistry and medicine, with a market cap of $0.41 million and quarterly net sales of $11 million as of September 2024. The company is currently operating at a net loss of $1 million.
How big is BIOLASE, Inc.?
As of Jun 18, BIOLASE, Inc. has a market capitalization of 0.41 million, with net sales of 46.02 million and a net profit of -16.05 million over the last four quarters. The company reported shareholder's funds of -0.25 million and total assets of 35.10 million as of Dec 23.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
